Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/06/2023 | 1.43% | Citigroup | → $17 | Initiates Coverage On | → Neutral |
05/11/2023 | 1.43% | Mizuho | $18 → $17 | Maintains | Neutral |
04/21/2023 | 19.33% | Raymond James | → $20 | Upgrades | Market Perform → Outperform |
04/18/2023 | 7.4% | Barclays | $19 → $18 | Maintains | Overweight |
03/07/2023 | 7.4% | JP Morgan | $17 → $18 | Maintains | Neutral |
03/07/2023 | 16.35% | Stifel | $20 → $19.5 | Upgrades | Hold → Buy |
02/02/2023 | 7.4% | Mizuho | $17 → $18 | Maintains | Neutral |
01/18/2023 | 13.37% | Barclays | $18 → $19 | Maintains | Overweight |
12/16/2022 | -4.53% | Wells Fargo | $18 → $16 | Downgrades | Overweight → Underweight |
11/04/2022 | 1.43% | Mizuho | $18 → $17 | Maintains | Neutral |
05/31/2022 | 7.4% | Wells Fargo | → $18 | Upgrades | Equal-Weight → Overweight |
05/11/2022 | 1.43% | Wells Fargo | $18 → $17 | Maintains | Equal-Weight |
04/28/2022 | 7.4% | Wells Fargo | $17 → $18 | Maintains | Equal-Weight |
03/22/2022 | 7.4% | JP Morgan | $17 → $18 | Maintains | Neutral |
02/07/2022 | 1.43% | Wells Fargo | → $17 | Downgrades | Overweight → Equal-Weight |
12/16/2021 | 1.43% | Wells Fargo | $19 → $17 | Maintains | Overweight |
11/05/2021 | — | UBS | Upgrades | Neutral → Buy | |
08/06/2021 | 1.43% | Barclays | $19 → $17 | Maintains | Overweight |
06/24/2021 | 25.3% | Wells Fargo | $20 → $21 | Maintains | Overweight |
05/13/2021 | 19.33% | Wells Fargo | $19 → $20 | Maintains | Overweight |
03/09/2021 | 31.26% | UBS | → $22 | Downgrades | Buy → Neutral |
01/20/2021 | 1.43% | JP Morgan | $14 → $17 | Upgrades | Underweight → Neutral |
01/06/2021 | — | B of A Securities | Downgrades | Neutral → Underperform | |
12/03/2020 | -10.5% | SMBC Nikko | → $15 | Initiates Coverage On | → Neutral |
11/30/2020 | — | Wells Fargo | Upgrades | Equal-Weight → Overweight | |
05/06/2020 | -22.43% | UBS | $12 → $13 | Maintains | Buy |
04/21/2020 | -28.4% | UBS | $18 → $12 | Maintains | Buy |
04/14/2020 | -4.53% | Wells Fargo | $18 → $16 | Maintains | Equal-Weight |
04/06/2020 | -16.47% | Mizuho | $33 → $14 | Maintains | Neutral |
04/03/2020 | 7.4% | UBS | $19 → $18 | Maintains | Buy |
03/25/2020 | 13.37% | UBS | $21 → $19 | Maintains | Buy |
03/11/2020 | -4.53% | Citigroup | $29 → $16 | Upgrades | Neutral → Buy |
02/05/2020 | — | UBS | Upgrades | Neutral → Buy | |
08/02/2019 | 90.93% | Mizuho | → $32 | Initiates Coverage On | → Neutral |
03/13/2019 | — | JP Morgan | Downgrades | Neutral → Underweight | |
01/11/2019 | 61.1% | B of A Securities | → $27 | Reinstates | → Neutral |
01/10/2019 | — | UBS | Downgrades | Buy → Neutral | |
11/29/2018 | 49.16% | Citigroup | $27 → $25 | Maintains | Neutral |
What is the target price for NuStar Energy (NS)?
The latest price target for NuStar Energy (NYSE: NS) was reported by Citigroup on October 6, 2023. The analyst firm set a price target for $17.00 expecting NS to rise to within 12 months (a possible 1.43% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for NuStar Energy (NS)?
The latest analyst rating for NuStar Energy (NYSE: NS) was provided by Citigroup, and NuStar Energy initiated their neutral rating.
When is the next analyst rating going to be posted or updated for NuStar Energy (NS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NuStar Energy, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NuStar Energy was filed on October 6, 2023 so you should expect the next rating to be made available sometime around October 6, 2024.
Is the Analyst Rating NuStar Energy (NS) correct?
While ratings are subjective and will change, the latest NuStar Energy (NS) rating was a initiated with a price target of $0.00 to $17.00. The current price NuStar Energy (NS) is trading at is $16.76, which is within the analyst's predicted range.